Streetwise Regenerative Medicine Sponsors
Select a name to see a detailed description, expert analysis and contact information.
– Douglas Loe, Echelon Wealth Partners
|"We are initiating coverage on RVX with a Buy rating."|
|"A revised underground mine plan is due by 2017E for ALK's Tomingley."|
|"RXII's sd-rxRNA can augment already amazing results in immunotherapy."|
|"We still believe GSV is undervalued."|